Skip to main content
Clinical Trials/NCT02204631
NCT02204631
Completed
Not Applicable

A Two-phase Study to Evaluate the Use of Educational Materials in the Head and Neck Cancer Center

Massachusetts General Hospital1 site in 1 country60 target enrollmentAugust 12, 2014

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Head and Neck Cancer
Sponsor
Massachusetts General Hospital
Enrollment
60
Locations
1
Primary Endpoint
Information Satisfaction Questionnaire (ISQ)
Status
Completed
Last Updated
8 years ago

Overview

Brief Summary

The goal of this study is to assess the experience of our patients with head and neck cancer in regard to the information they receive, their symptoms, and their understanding of their diagnosis, to determine ways to improve upon these aspects of patient care in the future.

Detailed Description

There will be two phases of the study. In "Phase I", 30 participants will be recruited for assessment of information satisfaction, psychological stress, illness perception, and symptom burden throughout their head and neck cancer treatment without any intervention. This group will represent the current standard of care in the head and neck group and serve as a "historical control" for the second group. In "Phase II", which will occur after "Phase I" group, 30 new participants will be recruited to receive a handbook and to have it integrated into their cancer care. The same participant reported outcome measures of information satisfaction, psychological stress, illness perception, and symptom burden will be assessed such that comparisons between phases can be made. This will serve as a pilot study of the implementation and maintenance of an educational intervention in clinical practice and how it affects participant-reported outcomes. Comparison of these two groups of participants will provide the baseline data to plan future interventions.

Registry
clinicaltrials.gov
Start Date
August 12, 2014
End Date
December 22, 2016
Last Updated
8 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Lori J. Wirth, MD

Principal Investigator

Massachusetts General Hospital

Eligibility Criteria

Inclusion Criteria

  • Adult patients (greater than 18 years old) with a new diagnosis of head and neck cancer.
  • Patients who have a treatment plan including both chemotherapy and radiation.
  • Patients who will be undergoing treatment at Massachusetts General Hospital Cancer Center.
  • Ability to speak and read in English in order to be able to complete questionnaires with minimal assistance required from a family member.

Exclusion Criteria

  • Patients with head and neck cancer who have a treatment plan only including single modality therapy (ie just radiation, just surgery, or just systemic therapy)
  • Patients who cannot speak, read and write in English with minimal assistance from a family member.
  • Patients with cognitive impairment that would preclude the patient signing informed consent or understanding the materials.
  • Patients who will not be receiving their cancer treatment at MGH.

Outcomes

Primary Outcomes

Information Satisfaction Questionnaire (ISQ)

Time Frame: Baseline, 4 Months, 6 Months

The primary endpoint will be the difference in scores on the Information Satisfaction Questionnaire (ISQ) between participants in Phase I and Phase II at 3 weeks into their treatment.

Secondary Outcomes

  • Percentage of participant change of scores of psychological distress(Baseline, 4 Months, 6 Months)
  • Percentage of Participant illness perception(Baseline, 4 Months, 6 Months)
  • Percentage of change participant symptom burden(Baseline, 4 Months, 6 Months)

Study Sites (1)

Loading locations...

Similar Trials